Nexcida Therapeutics
Menlo Park, US · Founded 2014 · Delaware corporation · 1 known investors
Founders & leadership
DS
David SocksNamed on SEC filing
Board
YG
Yigong GeBoard director
CY
Chen YuBoard director
PH
BA
Brent AhrensBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 1 round · 2015
▶$2.8MraisedJun 2015 · 5 investors · OtherRule 506(b)
▶$2.8MraisedJun 2015 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Yigong GeDirector
- Chen YuDirector
- Patrick HeronDirector
- Brent AhrensDirector
- David SocksExecutive Officer, Director, Promoter
- Offering amount
- $21.3M
- Amount sold
- $2.8M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nexcida Therapeutics's investors?
- Nexcida Therapeutics's investors include Frazier Life Sciences.
- How much funding has Nexcida Therapeutics raised?
- Nexcida Therapeutics has disclosed $2.8M raised across 1 round.
- Where is Nexcida Therapeutics headquartered?
- Nexcida Therapeutics is headquartered in Menlo Park, US.